Clinical Trial Update: Safety and Efficacy of APG-157 in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for APG-157 in head and neck squamous cell carcinomas; current status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Oral Cavity
• Squamous Cell Carcinoma of the Oropharynx

Drugs mentioned

• APG-157

Snippet

Sponsor: Aveta Biomics, Inc. | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of Oral Cavity | Phase 2 | Status: ACTIVE_NOT_RECRUITING